Toma Biosciences' Series C Round

Toma Biosciences raised a round of funding on July 25, 2018.

Toma Bioscience has developed a genomics testing platform, Signome Tumor Profiling System, that classifies tumors according to their genetic mutations by matching them against a panel of 130 cancerous…

Articles about Toma Biosciences' Series C Round: